{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T20:30:14Z","timestamp":1786739414768,"version":"build-2736575974"},"reference-count":76,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"7","license":[{"start":{"date-parts":[[2020,1,9]],"date-time":"2020-01-09T00:00:00Z","timestamp":1578528000000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:p>\n                    <jats:italic toggle=\"yes\">N<\/jats:italic>\n                    -formyl peptide receptors (FPRs) were first identified upon phagocytic leukocytes, but more than four decades of research has unearthed a plethora of non-myeloid roles for this receptor family. FPRs are expressed within neuronal tissues and markedly in the central nervous system, where FPR interactions with endogenous ligands have been implicated in the pathophysiology of several neurodegenerative diseases including Alzheimer\u2019s disease and Parkinson\u2019s disease, as well as neurological cancers such as neuroblastoma. Whilst the homeostatic function of FPRs in the nervous system is currently undefined, a variety of novel physiological roles for this receptor family in the neuronal context have been posited in both human and animal settings. Rapid developments in recent years have implicated FPRs in the process of neurogenesis and neuronal differentiation which, upon greater characterisation, could represent a novel pharmacological target for neuronal regeneration therapies that may be used in the treatment of brain\/spinal cord injury, stroke and neurodegeneration. This review aims to summarize the recent progress made to determine the physiological role of FPRs in a neuronal setting, and to put forward a case for FPRs as a novel pharmacological target for conditions of the nervous system, and for their potential to open the door to novel neuronal regeneration therapies.\n                  <\/jats:p>","DOI":"10.4103\/1673-5374.272566","type":"journal-article","created":{"date-parts":[[2020,1,9]],"date-time":"2020-01-09T08:22:53Z","timestamp":1578558173000},"page":"1191-1198","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":17,"title":["The N-formyl peptide receptors: contemporary roles in neuronal function and dysfunction"],"prefix":"10.4103","volume":"15","author":[{"given":"Peter J.G.","family":"Cussell","sequence":"first","affiliation":[{"name":"Centre for Biomedical Science Research, School of Clinical and Applied Sciences, Leeds Beckett University, Leeds, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margarita","family":"Gomez Escalada","sequence":"additional","affiliation":[{"name":"Centre for Biomedical Science Research, School of Clinical and Applied Sciences, Leeds Beckett University, Leeds, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathaniel G.N.","family":"Milton","sequence":"additional","affiliation":[{"name":"Centre for Biomedical Science Research, School of Clinical and Applied Sciences, Leeds Beckett University, Leeds, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3289-8738","authenticated-orcid":false,"given":"Andrew W.J.","family":"Paterson","sequence":"additional","affiliation":[{"name":"Centre for Biomedical Science Research, School of Clinical and Applied Sciences, Leeds Beckett University, Leeds, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2020,7]]},"reference":[{"key":"R1-20260525","doi-asserted-by":"crossref","first-page":"e1139275","DOI":"10.1080\/2162402X.2016.1139275","article-title":"Inhibition of formyl peptide receptor 1 reduces the efficacy of anticancer chemotherapy against carcinogen-induced breast cancer","volume":"5","author":"Baracco","year":"2016","journal-title":"Oncoimmunology"},{"key":"R2-20260525","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/s004410051042","article-title":"Broad immunocytochemical localization of the formylpeptide receptor in human organs, tissues, and cells","volume":"292","author":"Becker","year":"1998","journal-title":"Cell Tissue Res"},{"key":"R3-20260525","doi-asserted-by":"crossref","first-page":"6894","DOI":"10.1007\/s12035-018-0889-z","article-title":"Resolvin D1 halts remote neuroinflammation and improves functional recovery after focal brain damage via ALX\/FPR2 receptor-regulated microRNAs","volume":"55","author":"Bisicchia","year":"2018","journal-title":"Mol Neurobiol"},{"key":"R4-20260525","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1002\/ana.21527","article-title":"Multiple sodium channel isoforms and mitogen-activated protein kinases are present in painful human neuromas","volume":"64","author":"Black","year":"2008","journal-title":"Ann Neurol"},{"key":"R5-20260525","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/0304-3940(95)12192-7","article-title":"Interleukin-1 beta and interleukin-6 are elevated in the cerebrospinal fluid of Alzheimer\u2019s and de novo Parkinson\u2019s disease patients","volume":"202","author":"Blum-Degen","year":"1995","journal-title":"Neurosci Lett"},{"key":"R6-20260525","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1038\/bjc.2012.603","article-title":"Inhibition of formyl peptide receptor in high-grade astrocytoma by Chemotaxis Inhibitory Protein of S. aureus","volume":"108","author":"Boer","year":"2013","journal-title":"Br J Cancer"},{"key":"R7-20260525","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/1742-2094-8-11","article-title":"The formyl peptide receptor like-1 and scavenger receptor MARCO are involved in glial cell activation in bacterial meningitis","volume":"8","author":"Braun","year":"2011","journal-title":"J Neuroinflammation"},{"key":"R8-20260525","doi-asserted-by":"crossref","first-page":"471","DOI":"10.3389\/fphys.2018.00471","article-title":"The microbiome-mitochondria dance in prodromal Parkinson\u2019s disease","volume":"9","author":"Cardoso","year":"2018","journal-title":"Front Physiol"},{"key":"R9-20260525","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.1007\/s11064-010-0301-5","article-title":"Expression and signaling of formyl-peptide receptors in the brain","volume":"35","author":"Cattaneo","year":"2010","journal-title":"Neurochem Res,"},{"key":"R10-20260525","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1007\/s00415-012-6801-2","article-title":"Gastrointestinal manifestations in Parkinson\u2019s disease: prevalence and occurrence before motor symptoms","volume":"260","author":"Cersosimo","year":"2013","journal-title":"J Neurol"},{"key":"R11-20260525","doi-asserted-by":"crossref","first-page":"18232","DOI":"10.1073\/pnas.1308253110","article-title":"Ligand-specific conformational change of the G-protein-coupled receptor ALX\/FPR2 determines proresolving functional responses","volume":"110","author":"Cooray","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R12-20260525","doi-asserted-by":"crossref","first-page":"2000","DOI":"10.1097\/CCM.0b013e3181a001ae","article-title":"Monocyte activation by necrotic cells is promoted by mitochondrial proteins and formyl peptide receptors","volume":"37","author":"Crouser","year":"2009","journal-title":"Crit Care Med"},{"key":"R13-20260525","doi-asserted-by":"crossref","first-page":"e0217815","DOI":"10.1371\/journal.pone.0217815","article-title":"The formyl peptide receptor agonist FPRa14 induces differentiation of Neuro2a mouse neuroblastoma cells into multiple distinct morphologies which can be specifically inhibited with FPR antagonists and FPR knockdown using siRNA","volume":"14","author":"Cussell","year":"2019","journal-title":"PLoS One"},{"key":"R14-20260525","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.4049\/jimmunol.1003545","article-title":"Processing of HEBP1 by cathepsin D gives rise to F2L, the agonist of formyl peptide receptor 3","volume":"187","author":"Devosse","year":"2011","journal-title":"J Immunol"},{"key":"R15-20260525","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1016\/j.pharmthera.2010.04.010","article-title":"Therapeutic anti-inflammatory potential of formyl-peptide receptor agonists","volume":"127","author":"Dufton","year":"2010","journal-title":"Pharmacol Ther"},{"key":"R16-20260525","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1006\/geno.1998.5376","article-title":"Differential expansion of the N-formylpeptide receptor gene cluster in human and mouse","volume":"51","author":"Gao","year":"1998","journal-title":"Genomics"},{"key":"R17-20260525","doi-asserted-by":"crossref","first-page":"4977","DOI":"10.1096\/fj.12-205971","article-title":"Leukocyte recruitment in the brain in sepsis: involvement of the annexin 1-FPR2\/ALX anti-inflammatory system","volume":"26","author":"Gavins","year":"2012","journal-title":"FASEB J"},{"key":"R18-20260525","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1124\/mol.112.081315","article-title":"Functional characterization of three mouse formyl peptide receptors","volume":"83","author":"He","year":"2013","journal-title":"Mol Pharmacol"},{"key":"R19-20260525","doi-asserted-by":"crossref","DOI":"10.3390\/molecules22030455","article-title":"The formyl peptide receptors: diversity of ligands and mechanism for recognition","author":"He","year":"2017","journal-title":"Molecules"},{"key":"R20-20260525","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1007\/s11064-018-2573-0","article-title":"Localisation of formyl-peptide receptor 2 in the rat central nervous system and its role in axonal and dendritic outgrowth","volume":"43","author":"Ho","year":"2018","journal-title":"Neurochem Res"},{"key":"R21-20260525","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.canlet.2008.03.014","article-title":"Receptor \u201chijacking\u201d by malignant glioma cells: a tactic for tumor progression","volume":"267","author":"Huang","year":"2008","journal-title":"Cancer Lett"},{"key":"R22-20260525","doi-asserted-by":"crossref","first-page":"3174","DOI":"10.1074\/jbc.R115.702704","article-title":"Amyloid-beta receptors: the good, the bad, and the prion protein","volume":"291","author":"Jarosz-Griffiths","year":"2016","journal-title":"J Biol Chem"},{"key":"R23-20260525","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.expneurol.2017.11.005","article-title":"Combined administration of resolvin E1 and lipoxin A4 resolves inflammation in a murine model of Alzheimer\u2019s disease","volume":"300","author":"Kantarci","year":"2018","journal-title":"Exp Neurol"},{"key":"R24-20260525","doi-asserted-by":"crossref","first-page":"457","DOI":"10.3389\/fncel.2018.00457","article-title":"Mitochondrial damage-associated molecular patterns of injured axons induce outgrowth of Schwann cell processes","volume":"12","author":"Korimova","year":"2018","journal-title":"Front Cell Neurosci"},{"key":"R25-20260525","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/S1471-4906(02)02316-5","article-title":"Formyl-peptide receptors revisited","volume":"23","author":"Le","year":"2002","journal-title":"Trends Immunol"},{"key":"R26-20260525","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S1359-6101(01)00003-X","article-title":"Pleiotropic roles of formyl peptide receptors","volume":"12","author":"Le","year":"2001","journal-title":"Cytokine Growth Factor Rev"},{"key":"R27-20260525","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1111\/j.1742-4658.2004.04514.x","article-title":"Identification of functional domains in the formyl peptide receptor-like 1 for agonist-induced cell chemotaxis","volume":"272","author":"Le","year":"2005","journal-title":"FEBS J"},{"key":"R28-20260525","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1124\/mol.105.022103","article-title":"Serum amyloid A induces contrary immune responses via formyl peptide receptor-like 1 in human monocytes","volume":"70","author":"Lee","year":"2006","journal-title":"Mol Pharmacol"},{"key":"R29-20260525","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1189\/jlb.2RI0815-354RR","article-title":"New development in studies of formyl-peptide receptors: critical roles in host defense","volume":"99","author":"Li","year":"2016","journal-title":"J Leukoc Biol"},{"key":"R30-20260525","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1007\/s00109-013-1005-5","article-title":"Molecular biology for formyl peptide receptors in human diseases","volume":"91","author":"Li","year":"2013","journal-title":"J Mol Med (Berl)"},{"key":"R31-20260525","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1038\/eye.2014.226","article-title":"FPR1 interacts with CFH, HTRA1 and smoking in exudative age-related macular degeneration and polypoidal choroidal vasculopathy","volume":"28","author":"Liang","year":"2014","journal-title":"Eye (Lond)"},{"key":"R32-20260525","doi-asserted-by":"crossref","first-page":"6972","DOI":"10.1074\/jbc.272.11.6972","article-title":"Lipoxin A4 stable analogs are potent mimetics that stimulate human monocytes and THP-1 cells via a G-protein-linked lipoxin A4 receptor","volume":"272","author":"Maddox","year":"1997","journal-title":"J Biol Chem"},{"key":"R33-20260525","first-page":"101","article-title":"Symbiosis as a mechanism of evolution: status of cell symbiosis theory","volume":"1","author":"Margulis","year":"1985","journal-title":"Symbiosis"},{"key":"R34-20260525","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1186\/s12974-016-0540-8","article-title":"Lipoxin A4 inhibits microglial activation and reduces neuroinflammation and neuropathic pain after spinal cord hemisection","volume":"13","author":"Martini","year":"2016","journal-title":"J Neuroinflammation"},{"key":"R35-20260525","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1212\/WNL.38.8.1285","article-title":"Reactive microglia are positive for HLA-DR in the substantia nigra of Parkinson\u2019s and Alzheimer\u2019s disease brains","volume":"38","author":"McGeer","year":"1988","journal-title":"Neurology"},{"key":"R36-20260525","doi-asserted-by":"crossref","first-page":"e28712","DOI":"10.1371\/journal.pone.0028712","article-title":"Regulation of human formyl peptide receptor 1 synthesis: role of single nucleotide polymorphisms, transcription factors, and inflammatory mediators","volume":"6","author":"Miettinen","year":"2011","journal-title":"PLoS One"},{"key":"R37-20260525","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.cytogfr.2006.09.009","article-title":"Formyl peptide receptors: a promiscuous subfamily of G protein-coupled receptors controlling immune responses","volume":"17","author":"Migeotte","year":"2006","journal-title":"Cytokine Growth Factor Rev"},{"key":"R38-20260525","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1084\/jem.20041277","article-title":"Identification and characterization of an endogenous chemotactic ligand specific for FPRL2","volume":"201","author":"Migeotte","year":"2005","journal-title":"J Exp Med"},{"key":"R39-20260525","doi-asserted-by":"crossref","first-page":"81","DOI":"10.2165\/00002512-200421020-00002","article-title":"Role of hydrogen peroxide in the aetiology of Alzheimer\u2019s disease: implications for treatment","volume":"21","author":"Milton","year":"2004","journal-title":"Drugs Aging"},{"key":"R40-20260525","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/0304-3940(94)90746-3","article-title":"Tumor necrosis factor-alpha (TNF-alpha) increases both in the brain and in the cerebrospinal fluid from parkinsonian patients","volume":"165","author":"Mogi","year":"1994","journal-title":"Neurosci Lett"},{"key":"R41-20260525","doi-asserted-by":"crossref","first-page":"20","DOI":"10.2174\/187152312803476246","article-title":"Role of formyl peptide receptors (FPR) in abnormal inflammation responses involved in neurodegenerative diseases","volume":"11","author":"Mollica","year":"2012","journal-title":"Antiinflamm Antiallergy Agents Med Chem"},{"key":"R42-20260525","doi-asserted-by":"crossref","DOI":"10.3390\/ijms19071884","article-title":"Cellular receptors of amyloid beta oligomers (AbetaOs) in Alzheimer\u2019s disease","author":"Mroczko","year":"2018","journal-title":"Int J Mol Sci"},{"key":"R43-20260525","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1007\/s00239-015-9666-z","article-title":"Adaptive evolution of formyl peptide receptors in mammals","volume":"80","author":"Muto","year":"2015","journal-title":"J Mol Evol"},{"key":"R44-20260525","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.acthis.2007.10.003","article-title":"Glial cells: old cells with new twists","volume":"110","author":"Ndubaku","year":"2008","journal-title":"Acta Histochem"},{"key":"R45-20260525","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/B978-0-12-152817-1.50009-2","article-title":"Formyl peptide chemotactic receptors of leukocytes and macrophages","volume":"17","author":"Niedel","year":"1980","journal-title":"Curr Top Cell Regul"},{"key":"R46-20260525","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1038\/s41582-019-0215-z","article-title":"Prodromal Parkinson disease: do we miss the signs?","volume":"15","author":"Postuma","year":"2019","journal-title":"Nat Rev Neurol"},{"key":"R47-20260525","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1002\/mds.24993","article-title":"Lewy pathology in gastric and duodenal biopsies in Parkinson\u2019s Disease","volume":"27","author":"Pouclet","year":"2012","journal-title":"Mov Disord"},{"key":"R48-20260525","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.phrs.2015.09.017","article-title":"Formyl peptide receptors at the interface of inflammation, angiogenesis and tumor growth","volume":"102","author":"Prevete","year":"2015","journal-title":"Pharmacol Res"},{"key":"R49-20260525","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0163-7258(96)00203-3","article-title":"The N-formyl peptide receptor: a model for the study of chemoattractant receptor structure and function","volume":"74","author":"Prossnitz","year":"1997","journal-title":"Pharmacol Ther"},{"key":"R50-20260525","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.bbamcr.2018.11.015","article-title":"Biased perspectives on formyl peptide receptors","volume":"1866","author":"Raabe","year":"2019","journal-title":"Biochim Biophys Acta Mol Cell Res"},{"key":"R51-20260525","doi-asserted-by":"crossref","first-page":"26718","DOI":"10.1074\/jbc.M111.244590","article-title":"N-formyl peptide receptor 3 (FPR3) departs from the homologous FPR2\/ALX receptor with regard to the major processes governing chemoattractant receptor regulation, expression at the cell surface, and phosphorylation","volume":"286","author":"Rabiet","year":"2011","journal-title":"J Biol Chem"},{"key":"R52-20260525","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1038\/nature09615","article-title":"The myeloid cells of the central nervous system parenchyma","volume":"468","author":"Ransohoff","year":"2010","journal-title":"Nature"},{"key":"R53-20260525","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1186\/s12974-016-0692-6","article-title":"The anti-inflammatory Annexin A1 induces the clearance and degradation of the amyloid-beta peptide","volume":"13","author":"Ries","year":"2016","journal-title":"J Neuroinflammation"},{"key":"R54-20260525","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1038\/nature08029","article-title":"Formyl peptide receptor-like proteins are a novel family of vomeronasal chemosensors","volume":"459","author":"Riviere","year":"2009","journal-title":"Nature"},{"key":"R55-20260525","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/S0074-7742(07)82012-5","article-title":"Neuroinflammation in Alzheimer\u2019s disease and Parkinson\u2019s disease: are microglia pathogenic in either disorder?","volume":"82","author":"Rogers","year":"2007","journal-title":"Int Rev Neurobiol"},{"key":"R56-20260525","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1016\/j.cell.2016.11.018","article-title":"Gut microbiota regulate motor deficits and neuroinflammation in a model of Parkinson\u2019s disease","volume":"167","author":"Sampson","year":"2016","journal-title":"Cell"},{"key":"R57-20260525","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1073\/pnas.72.3.1059","article-title":"N-formylmethionyl peptides as chemoattractants for leucocytes","volume":"72","author":"Schiffmann","year":"1975","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R58-20260525","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1161\/CIRCULATIONAHA.118.039345","article-title":"Novel role for the AnxA1-Fpr2\/ALX signaling axis as a key regulator of platelet function to promote resolution of inflammation","volume":"140","author":"Senchenkova","year":"2019","journal-title":"Circulation"},{"key":"R59-20260525","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1186\/s12885-016-2545-1","article-title":"The role of formyl peptide receptor 1 (FPR1) in neuroblastoma tumorigenesis","volume":"16","author":"Snapkov","year":"2016","journal-title":"BMC Cancer"},{"key":"R60-20260525","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/0167-4889(96)00048-1","article-title":"Involvement of the beta gamma subunits of inhibitory GTP-binding protein in chemoattractant receptor-mediated potentiation of cyclic AMP formation in guinea pig neutrophils","volume":"1313","author":"Suzuki","year":"1996","journal-title":"Biochim Biophys Acta"},{"key":"R61-20260525","doi-asserted-by":"crossref","first-page":"23645","DOI":"10.1074\/jbc.M101031200","article-title":"Amyloid-beta induces chemotaxis and oxidant stress by acting at formylpeptide receptor 2, a G protein-coupled receptor expressed in phagocytes and brain","volume":"276","author":"Tiffany H","year":"2001","journal-title":"J Biol Chem"},{"key":"R62-20260525","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.1161\/CIRCULATIONAHA.115.020633","article-title":"Formyl-peptide receptor 2\/3\/lipoxin A4 receptor regulates neutrophil-platelet aggregation and attenuates cerebral inflammation: impact for therapy in cardiovascular disease","volume":"133","author":"Vital","year":"2016","journal-title":"Circulation"},{"key":"R63-20260525","doi-asserted-by":"crossref","first-page":"25946","DOI":"10.1038\/srep25946","article-title":"Formylpeptide receptors promote the migration and differentiation of rat neural stem cells","volume":"6","author":"Wang","year":"2016","journal-title":"Sci Rep"},{"key":"R64-20260525","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1016\/j.it.2018.08.005","article-title":"Formyl-peptide receptors in infection, inflammation, and cancer","volume":"39","author":"Weiss","year":"2018","journal-title":"Trends Immunol"},{"key":"R65-20260525","doi-asserted-by":"crossref","first-page":"33259","DOI":"10.1074\/jbc.274.47.33259","article-title":"Quantitative analysis of formyl peptide receptor coupling to g(i)alpha(1), g(i)alpha(2), and g(i)alpha(3)","volume":"274","author":"Wenzel-Seifert","year":"1999","journal-title":"J Biol Chem"},{"key":"R66-20260525","doi-asserted-by":"crossref","first-page":"305","DOI":"10.3233\/JAD-142334","article-title":"Mitochondrial lysates induce inflammation and Alzheimer\u2019s disease-relevant changes in microglial and neuronal cells","volume":"45","author":"Wilkins","year":"2015","journal-title":"J Alzheimer\u2019s Dis"},{"key":"R67-20260525","first-page":"579","article-title":"Synthetic peptide chemotactic factors for neutrophils: the range of active peptides, their efficacy and inhibitory activity, and susceptibility of the cellular response to enzymes and bacterial toxins","volume":"36","author":"Wilkinson","year":"1979","journal-title":"Immunology"},{"key":"R68-20260525","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1016\/j.ajpath.2011.05.059","article-title":"Annexin 1 released by necrotic human glioblastoma cells stimulates tumor cell growth through the formyl peptide receptor 1","volume":"179","author":"Yang","year":"2011","journal-title":"Am J Pathol"},{"key":"R69-20260525","doi-asserted-by":"crossref","first-page":"2454","DOI":"10.1096\/fj.01-0251com","article-title":"Beta amyloid peptide (Abeta42) is internalized via the G-protein-coupled receptor FPRL1 and forms fibrillar aggregates in macrophages","volume":"15","author":"Yazawa","year":"2001","journal-title":"FASEB J"},{"key":"R70-20260525","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1124\/pr.109.001578","article-title":"International union of basic and clinical pharmacology. LXXIII.Nomenclature for the formyl peptide receptor (FPR) family","volume":"61","author":"Ye","year":"2009","journal-title":"Pharmacol Rev"},{"key":"R71-20260525","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/s10571-014-0101-6","article-title":"Microglial Abeta receptors in Alzheimer\u2019s disease","volume":"35","author":"Yu","year":"2015","journal-title":"Cell Mol Neurobiol"},{"key":"R72-20260525","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1186\/s13054-017-1757-3","article-title":"The common promoter polymorphism rs11666254 downregulates FPR2\/ALX expression and increases risk of sepsis in patients with severe trauma","volume":"21","author":"Zhang","year":"2017","journal-title":"Crit Care"},{"key":"R73-20260525","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1038\/s41598-017-00314-5","article-title":"Formyl peptide receptors promotes neural differentiation in mouse neural stem cells by ROS generation and regulation of PI3K-AKT signaling","volume":"7","author":"Zhang","year":"2017","journal-title":"Sci Rep"},{"key":"R74-20260525","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.jneuroim.2010.08.012","article-title":"Gene expression profiling in peripheral blood mononuclear cells from patients with sporadic amyotrophic lateral sclerosis (sALS)","volume":"230","author":"Zhang","year":"2011","journal-title":"J Neuroimmunol"},{"key":"R75-20260525","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1093\/jnci\/dji142","article-title":"Formylpeptide receptor FPR and the rapid growth of malignant human gliomas","volume":"97","author":"Zhou","year":"2005","journal-title":"J Natl Cancer Inst"},{"key":"R76-20260525","doi-asserted-by":"crossref","first-page":"1756286418791107","DOI":"10.1177\/1756286418791107","article-title":"Can inflammation be resolved in Alzheimer\u2019s disease?","volume":"11","author":"Zhu","year":"2018","journal-title":"Ther Adv Neurol Disord"}],"container-title":["Neural Regeneration Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/1673-5374.272566","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T19:28:47Z","timestamp":1786735727000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/1673-5374.272566"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1,9]]},"references-count":76,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.4103\/1673-5374.272566","relation":{},"ISSN":["1673-5374","1876-7958"],"issn-type":[{"value":"1673-5374","type":"print"},{"value":"1876-7958","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,1,9]]},"assertion":[{"value":"2019-09-17","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-11-12","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}